We need to report misconduct from whoever is creating and signing off on comp plans- Looking at you - ryan rizzo. Also looking at the signees on the playbooks. There are some interesting trends in performance reports when you dig in. There are ethical ramifications to providing false data. That is the only thing that catches the attention of anyone who can call for change. We all know Retalition is the silent additional core pillar here so no one says anything.
this business unit has been disfunctional and chaotic for more than 3 years.
A couple things to consider:
Entresto - there’s a lot of celebrating but bonuses are more dismal than ever.why are leqvio reps tasked with providing samples and resources and not compensated. Former cv reps have been screwed since 2020 while former pcp reps got bonused on hospitalists and cardiology mid levels. This has happened company wide and reported many times.but there is never any action. Why? CV leaders have made the decision to screw the the remaining reps who launched and built the brand that is bringing the lions share of US revenue.
Leqvio - this has to be the shadiest reporting in pharma. Why can’t the injections be tracked. Fu & your teamwork approach. All hands on deck endures no gets paid. Why is the data top secret? Sell sell sell- well we are, but we sharing compensation with multiple reps in multiple areas. We may be 1CV but this approach isn’t cutting it. I know of at least 4 people resigning after this weeks non bonus. I can’t wait to see the overall resignation number.
kpi’s - it’s widely discussed and reported that the last reorganization has been detrimental to business. But where are the leaders. How long do we wait to say, yup- we messed up. The company treats reps as disposable entities and yes, we are replaceable at any time. But it’s a mistake to bench experienced performing reps because a drunk uncle vp gets a wild hair. It’s a mistake to listen to strategy from inexperienced new reps.
I don’t know Diane and Kristen but someone should tell them copay cards and resources to help us sell aka make more money for Novartis does not fix culture. Clearly you were not listening and you didn’t hear us.